Atlas FDA

NOVOTTF-100A SYSTEM

FDA premarket approval P100034/S006 · decided 2013-09-19

Approval details

PMA number
P100034
Supplement
S006
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
NOVOTTF-100A SYSTEM
Generic name
Stimulator, low electric field, tumor treatment
Applicant
Novocure, GmbH
Date received
2013-08-20
Decision date
2013-09-19
Days to decision
30 days
Decision code
OK30
Product code
NZK
Advisory committee
Neurology
Expedited review
No
Location
Baar
Statement
CHANGE TO THE MANUFACTURING PRODUCTION FLOW TO INCLUDE DISTRIBUTION LOGISTICS THAT WILL BE PERFORMED BY NOVOCURE GMBH IN ROOT LUZERN, SWITZERLAND.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.